Bengt Arne Gustavsson

Bengt Arne Gustavsson is currently the Chairman & CEO of Sangus Jazz AB, a Director at Wntresearch AB, and an Independent Director & Medical Director at Nanexa AB.
He previously worked as the Director-Nordic Clinical Research at Sanofi Aventis AB from 2005 to 2007, Director-Nordic Medical at Novartis Oncology Switzerland from 2002 to 2005 and again from 2007 to 2011, Global Head-Medical Affairs at Oncopeptides AB, and Head-Nordic Medical at Celgene AB from 2012 to 2017.
Gustavsson holds a doctorate and an undergraduate degree from the University of Uppsala and an undergraduate degree from the University of Basel.